EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Peripheral Insulin Resistance and Alzheimer's Disease: Possible Mediators Including Extracellular Vesicles

Naotaka Izuo iD, Hiroshi Kondoh, Takahiko Shimizu iD

Geriatrics & Gerontology International · 2026-04 · 26 (4)

DOI: 10.1111/ggi.70483 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Geriatrics & Gerontology International, online erschienen am 13.04.2026. Verfasst von Naotaka Izuo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, Insulin Resistance, Diabetes Mellitus, Type 2, Extracellular Vesicles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidemiological studies consistently indicate that type 2 diabetes mellitus increases the risk of Alzheimer's disease (AD). Accumulating evidence suggests that insulin resistance, rather than hyperglycemia per se, is the principal metabolic factor associated with AD development. Population‐based longitudinal studies show that insulin resistance is strongly linked to earlier amyloid β (Aβ) accumulation, whereas its association with tau pathology remains inconsistent. Importantly, insulin resistance‐related cognitive decline and earlier disease onset cannot be fully explained by the extent of Aβ deposition alone, implying the involvement of additional pathogenic pathways. Animal studies further support a role for insulin resistance independent of sustained hyperglycemia. Genetic models of systemic insulin resistance demonstrate impairments in cognition, cerebral blood flow regulation, and emotional behavior, distinct from phenotypes observed in models with brain‐specific disruption of insulin signaling. Together with clinical observations showing preserved central insulin responsiveness in individuals with type 2 diabetes, these findings highlight peripheral insulin resistance as a key contributor to brain vulnerability in AD. How peripheral insulin resistance influences the brain remains incompletely understood. Emerging evidence suggests that extracellular vesicles may act as a possible mediator of peripheral–central communication by conveying bioactive molecules across tissues. In this review, we summarize epidemiological and experimental evidence linking peripheral insulin resistance to AD and discuss the potential, yet still speculative, role of extracellular vesicles in this process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseInsulin ResistanceDiabetes Mellitus, Type 2Extracellular VesiclesHumansAnimalsAmyloid beta-PeptidesBrain

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid βextracellular vesiclesinsulin resistancetype 2 diabetes mellitus

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Geriatric Unit, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Food and Reproductive Function Advanced Research, Juntendo University Graduate School of Medicine, Tokyo, Japan.

ORCID-Profile: Naotaka Izuo, Takahiko Shimizu

Zitieren

APA

Izuo, N., Kondoh, H., & Shimizu, T. (2026). Peripheral Insulin Resistance and Alzheimer's Disease: Possible Mediators Including Extracellular Vesicles. Geriatrics & Gerontology International, 26(4). https://doi.org/10.1111/ggi.70483

Vancouver

Izuo N, Kondoh H, Shimizu T. Peripheral Insulin Resistance and Alzheimer's Disease: Possible Mediators Including Extracellular Vesicles. Geriatrics & Gerontology International. 2026;26(4). doi:10.1111/ggi.70483

BibTeX
@article{Izuo2026,
  author = {Izuo, Naotaka and Kondoh, Hiroshi and Shimizu, Takahiko},
  title = {Peripheral Insulin Resistance and Alzheimer's Disease: Possible Mediators Including Extracellular Vesicles},
  journal = {Geriatrics & Gerontology International},
  year = {2026},
  volume = {26},
  number = {4},
  doi = {10.1111/ggi.70483}
}
Kostenlos starten →